Form 4: Bicycle Therapeutics COO Alistair Milnes Sells Shares to Cover Tax Obligations

Alistair Milnes, COO of Bicycle Therapeutics PLC, sold shares to cover statutory tax withholding obligations related to the vesting and settlement of restricted stock units.

Summary

• Alistair Milnes, the Chief Operating Officer of Bicycle Therapeutics PLC, sold shares of the company's ordinary stock on April 2nd and 3rd, 2025.
• The sales were executed to cover statutory tax withholding obligations associated with the vesting and settlement of restricted stock units.
• On April 2nd, 1,133 shares were sold at a weighted average price of $8.02, with individual prices ranging from $8.00 to $8.12.
• On April 3rd, 1,038 shares were sold at a weighted average price of $7.48, with individual prices ranging from $7.43 to $7.50.
• Following these transactions, Milnes directly owns 97,617 ordinary shares of Bicycle Therapeutics PLC.

Sentiment

Score: 6

Explanation: The document is neutral as it reports routine stock sales for tax purposes. It doesn't indicate any significant positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This filing indicates that the COO is selling shares to cover tax obligations, which is a common practice.

Stakeholder Impact

• The stock sales could have a minor, temporary impact on the stock price, but are unlikely to significantly affect stakeholders.

Key Dates

Keywords

Bicycle Therapeutics, BCYC, Alistair Milnes, stock sale, Form 4, tax withholding, restricted stock units, COO